Bacteria shed light on toxic medicine

Feb 15, 2011 By Marian de Boo

A new method developed in Wageningen should facilitate the early testing of drugs, reducing costs and the need for animal testing.

Many of the medical drugs that are developed do not make the grade in the end because they turn out to have toxic side effects. And this is usually only discovered in the last phase, when there is enough of the drug available for a trial. By that time years of investment have gone into the drug.

Wageningen University molecular biologist Walter Westering has developed a method for testing potential new medicines for possible at a very early stage, when there are just a few milligrams of the substance available. Westerink, who used to work for MSD (formerly Organon), received his PhD on 4 February 2011 from Professor Ivonne Rietjens of the Toxicology department.

The most common side effect identified at Organon is genotoxicity, or DNA damage. Westering set out to find in vitro testing methods that could be carried out faster so as to test many potential drugs for genotoxicity. "The big advantage of early testing is that you can still adjust the to make a substance less toxic and more effective."

Gene toxicity can come about when substances stick to the DNA or react to proteins that are important for cell division. This leads to subtle gene mutations or less subtle chromosome damage, causing complete to break in two or even to change in numbers. The Ames test is a classic test on strains, for identifying gene mutations. As soon as occurs, the bacteria set about repairing it. To do this they make use of certain genes.

In his PhD research, Westering equipped these bacteria with the luciferase gene, taken from the firefly. When the bacteria start carrying out repairs, you see them light up. This is very easy to measure and you do not need a large amount of the substance to do this test. Westerink: "Of the ten genotoxic candidates, we can now track down eight at an early stage. In the end we will not need to do as much , thanks to these new tests."

Explore further: Mycologist promotes agarikon as a possibility to counter growing antibiotic resistance

Provided by Wageningen University

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Teaching old drugs new tricks

Jul 10, 2008

Researchers from the European Molecular Biology Laboratory discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs ...

Drug tests will prevent repeat of Northwick Park trial

Dec 16, 2008

Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.

Pinhead-size worms + robot = new antibiotics

Aug 05, 2009

In an advance that could help ease the antibiotic drought, scientists in Massachusetts are describing successful use of a test that enlists pinhead-sized worms in efforts to discover badly needed new antibiotics. ...

Recommended for you

YEATS protein potential therapeutic target for cancer

Oct 23, 2014

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

Oct 23, 2014

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0